ITEMS IN AFP WITH KEYWORD:
Family Planning and Contraception
Oral mifepristone (Mifeprex), ulipristal (Ella), levonorgestrel-releasing emergency contraception (Plan B One-Step), ethinyl estradiol/levonorgestrel, and the copper intrauterine device (IUD; Paragard) are safe and effective for emergency contraception.
Annovera is an effective combined progestin/estrogen contraceptive device that can be used for one year.
When treated with letrozole, subfertile women with PCOS who are trying to conceive have increased chances of pregnancy (number needed to treat [NNT] = 11) and live birth (NNT = 10) compared with those treated with clomiphene.
Although most long-acting reversible contraception insertions and removals are straightforward, with the rise in the use of intrauterine devices and implants, clinicians are more likely to encounter challenges with these procedures. Learn strategies for managing difficult cases.
The etonogestrel subdermal implant is approved by the U.S. Food and Drug Administration for contraception for up to three years, but it seems to be effective for up to five years.
Providing immediate postpartum LARC to women who want it is an evidence-based, patient-centered, and safe practice.
Dec 1, 2017 Issue
Local Anesthesia for IUD Insertion or Endometrial Biopsy [FPIN's Help Desk Answers]
Topical application of lidocaine/prilocaine cream to the cervix reduces mean pain scores during IUD insertion. Intrauterine instillation of liquid anesthesia reduces median pain scores during endometrial biopsy.
Jun 1, 2017 Issue
Hormonal Contraceptives in Women Who Are Overweight or Obese [FPIN's Help Desk Answers]
Hormonal contraceptives (oral contraceptive pills, implants, patches, and rings) are highly effective in women of all weights.There is no consistently demonstrated increased risk of pregnancy in overweight women using any specific hormonal method of contraception.
Among adolescents, educational interventions increase reported condom use at most recent intercourse, whereas contraceptive-promoting interventions increase use of hormonal contraception.
The Centers for Disease Control and Prevention (CDC) first published the U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) in 2013 to provide direction for safe and effective use of contraceptive methods. These guidelines update the 2013 report.